Clinical Trial Update: Relationship Between T LYmphocytes Depletion and Clinical Response to RITUXimab in Rheumatoid Arthritis (LYRITUX) [Phase 3]

View source ↗

Summary

Phase 3 trial update examining the relationship between T lymphocyte depletion and clinical response to Rituximab in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University Hospital, Tours | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED